22q11.2 deletion syndrome (22q11.2DS) is a disorder caused by recurrent, chromosomespecific, low copy repeat (LCR)-mediated copy-number losses of chromosome 22q11. The Children's Hospital of Philadelphia has been involved in the clinical care of individuals with what is now known as 22q11.2DS since our initial report of the association with DiGeorge syndrome in 1982. We reviewed the medical records on our continuously growing longitudinal cohort of 1,421 patients with molecularly confirmed 22q11.2DS from 1992 to 2018. Most individuals are Caucasian and older than 8 years. The mean age at diagnosis was 3.9 years. The majority of patients (85%) had typical LCR22A-LCR22D deletions, and only 7% of these typical deletions were inherited from a parent harboring the deletion constitutionally. However, 6% of individuals harbored other nested deletions that would not be identified by traditional 22q11.2 FISH, thus requiring an orthogonal technology to diagnose. Major medical problems included immune dysfunction or allergies (77%), palatal abnormalities (67%), congenital heart disease (64%), gastrointestinal difficulties (65%), endocrine dysfunction (>50%), scoliosis (50%), renal anomalies (16%), and airway abnormalities. Median full-scale intelligence quotient was 76, with no significant difference between individuals with and without congenital heart disease or hypocalcemia. Characteristic dysmorphic facial features were present in most individuals, but dermatoglyphic patterns of our cohort are similar to normal controls. This is the largest longitudinal study of patients with 22q11.2DS, helping to further describe the condition and aid in diagnosis and management.
Further surveillance will likely elucidate additional clinically relevant findings as they age.
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| INTRODUCTION
Deletions of sub-band 11.2 of the long-arm of chromosome 22 are estimated to be as common as 1 in 3,000-6,000 live births (Botto et al., 2003; Carey et al., 1992; Devriendt, Fryns, Mortier, van Thienen, & Keymolen, 1998; Goodship, Cross, LiLing, & Wren, 1998; Oskarsdóttir, Vujic, & Fasth, 2004; Scambler, 2000; Wilson, Goodship, Burn, Cross, & Scambler, 1992) and approximately 1 in 1,000 fetuses (Grati et al., 2015) . These deletions are pathogenic variants causing a range of phenotypes previously classified as DiGeorge syndrome (Driscoll, Budarf, & Emanuel, 1992; Kelley et al., 1982; la Chapelle, Herva, Koivisto, & Aula, 1981; Scambler et al., 1991) , velocardiofacial syndrome (Driscoll, Spinner et al., 1992 , conotruncal anomaly face syndrome (Burn et al., 1993; Matsuoka et al., 1994) , autosomal dominant Opitz G/BBB syndrome (Fryburg, Lin, & Golden, 1996; Lacassie & Arriaza, 1996; McDonald-McGinn et al., 1995) , and Cayler cardiofacial syndrome (Bawle, Conard, Van Dyke, Czarnecki, & Driscoll, 1998; Giannotti, Digilio, Marino, Mingarelli, & Dallapiccola, 1994) .
The 22q11.2 deletion syndrome (22q11.2DS) owes this number of previously described entities to the diverse medical subspecialists who originally classified the genetic condition, each focusing on their specific areas of interest and signs and symptoms related to these subspecialties. However, the development and widespread use of fluorescence in situ hybridization (FISH) allowed for these conditions to be collectively referred to by their underlying molecular etiology, the 22q11.2DS (McDonald-McGinn, Emanuel, & Zackai, 1996) . The range of associated clinical features is broad and variably expressive.
These features include immunodeficiency, congenital heart disease, palatal defects, hypocalcemia, dysphagia, renal anomalies, and developmental disabilities .
Previous studies have revealed that most individuals affected with 22q11.2DS have a recurrent three megabase deletion, which includes approximately 50 genes. Of those with a nonstandard deletion, a majority have a smaller nested deletion that also results in haploinsufficiency of the "DiGeorge critical region" (Gong et al., 1996; McDonald-McGinn et al., 2015) . Some of the genes located within the standard deletion have major clinical impact, such as UFD1L, COMT, and particularly T-box 1 (TBX1). The TBX1 gene is part of the larger family of T-box genes, which help to regulate tissue and organ formation during development (Baldini, 2005) . However, a different minority of patients harbor nested distal deletions but retain two copies of the TBX1 gene (Amati et al., 1999; Garcia-Miñaur et al., 2002; Kurahashi et al., 1996; McDonald-McGinn et al., 2015; McQuade et al., 1999; O'Donnell, McKeown, Gould, Morrow, & Scambler, 1997; Yamagishi, Garg, Matsuoka, Thomas, & Srivastava, 1999) . Nonetheless, these individuals are haploinsufficient for other apparently developmentally important genes such as CRKL (Racedo et al., 2015) . Some Previous studies indicate that a substantial majority of patients with 22q11.2DS harbor de novo deletions of 22q11.2 (McDonaldMcGinn et al., 2001 (McDonaldMcGinn et al., , 2015 . The recurrent nature of the deletion is a result of nonallelic homologous recombination that occurs during meiosis between several segmental duplications or low copy repeats (LCR22A, LCR22B, LCR22C, and LCR22D) flanking the critical region.
High-sequence identity among modular elements within LCRs makes the region particularly vulnerable to genomic rearrangements because of nonallelic homologous recombination (Baumer, Riegel, & Schinzel, 2004; Edelmann, Pandita, & Morrow, 1999; McDonald-McGinn et al., 2015; Saitta et al., 2004; Shaikh et al., 2000) . Previous studies suggest that individuals with the deletion have an approximately 50% risk of having an affected child with each offspring.
There has been much advancement in the treatment of children with this syndrome since 1992. However, findings from a sizeable cohort remain relevant to the field. Here, we report our observations on 1,421 patients with 22q11.2DS, including demographics, physical examination findings, molecular genetics, inheritance, medical comorbidity, and mortality.
| METHODS
The Institutional Review Board at the Children's Hospital of Philadelphia (CHOP) approved this longitudinal study. We enrolled 1,421 individuals with a diagnosis of 22q11.2DS diagnosed using FISH, multiplex ligation-dependent probe amplification (MLPA), or chromosomal microarray between 1992 and 2018. The medical records of these patients were obtained and manually reviewed to provide the clinical data presented here. Not all individuals were assessed for all phenotypes; in most cases, results are reported as percentages of total individuals with available data. Congenital heart disease was classified based on a previously reported standard by Billett, Cowie, Gatzoulis, Vonder Muhll, and Majeed, (2008) as complex, moderate, or simple.
Data analysis and statistical testing were performed using the R Statistical Programming Language.
| RESULTS
Males and females were equally likely to reach clinical attention; 51% of this cohort was male, whereas 49% was female (Table 1) . Our cohort was primarily Caucasian, with individuals of African ancestry being the second largest ethnicity represented. Our cohort was also aging; at the time of analysis in 2018, 53% was older than 18 years.
This age represented the current age of the patients, not necessarily the age of most recent evaluation.
| Physical features
The majority of individuals in our pediatric cohort were examined by a single medical geneticist (E.H.Z.). (Preus & Fraser, 1972) of individuals were analyzed. Ulnar loops were the prominent dermatoglyph (Figure 1 ).
The patterns observed in patients with 22q11.2DS were not substantially different from previously reported healthy controls (Plato, Cereghino, & Steinberg, 1975) . 
| Diagnosis
The median age of diagnosis was 360 days (Figure 2 ). Notably, the mean age at diagnosis is substantially longer at 3.9 years with a standard error of 0.24 years, underscoring the long diagnostic odyssey for many of our patients. Arriving at a diagnosis was significantly easier for individuals with cardiac disease, with a median age at diagnosis of 2.6 months compared to those without cardiac issues of 3.1 years (p < 0.0001, Wilcoxon signed-rank test). Among those without heart disease, the diagnosis remained challenging with common features such as ear abnormalities, hooding of the eyes, and nose differences or even seemingly more specific abnormalities such as asymmetric 
| Molecular genetics
Although some patients in our cohort have only had molecular testing by FISH (29%), most had additional, more detailed testing by MLPA or chromosomal microarray. Among individuals with better characterized pathogenic variants (60%), the vast majority (84%) had the standard LCR22A-LCR22D deletion, with 14% having other LCR-mediated deletions (Table 3) . Notably, LCR22B-LCR22D, LCR22C-LCR22D, and other atypical deletions would not be identified by FISH testing, as they result in normal copy number of the region interrogated by the probes used to conduct the test. We also observed a few individuals (2%) with deletions that do not appear to be LCR-mediated.
Although patients with the standard LCR22A-LCR22D deletion most frequently exhibit de novo variants, not detected in either parent, cases with nested deletions were more likely to be familial. In fact, 60% of LCR22B-LCR22D or LCR22C-LCR22D index cases have family members harboring the deletion, in contradistinction to just 7% of the overall 22q11.2 deletion cohort. In addition, we observed one somatically mosaic patient, one presumed germline mosaic patient, and three families with a proband with a 22q11.2 deletion and a parent with a mosaic 22q11.2 duplication.
| Developmental milestones
Individuals in our cohort sat at a median age of 8 months and walked alone at a median age of 16 months ( Figure 3a) . Our patients spoke their first words at a median age of 19 months and were using simple phrases by a median age of 34.5 months (Figure 3b ). Among those who spoke words, 95% had done so by 42 months, whereas, 95% had made simple phrases by 58 months.
The median age for sitting and walking independently by individuals with cardiac disease was 1 month slower and 3 months slower, respectively, compared to individuals without heart issues (p = 0.045, p = 0.005, respectively, Wilcoxon signed-rank test, Figure 3c ). However, there was neither significant difference between the time of first words nor full sentences between individuals with and without cardiac disease (p = 0.30, p = 0.25, respectively, Wilcoxon signed-rank test).
Interestingly, there was neither significant difference between the time of first words nor speaking in full sentences among individuals with or without overt or submucous cleft palate (Supporting Information Figure S1 , p = 0.87, p = 0.17, respectively, Wilcoxon signed-rank test), and they were not significantly more likely to receive speech therapy (p = 0.26, Fisher exact test). However, our cohort is not powered well to identify these effects, as overt or submucous cleft palate was rare in our population.
| Growth
A previous study including a subset of our cohort revealed that patients with 22q11.2DS experience growth faltering from 6 to 9 months of age, followed by a catch-up period. Individuals' weight ultimately recovered close to the reference population (mean of Table 4 lists selected common medical conditions.
| Immune dysfunction or allergies
The most common medical issue in our cohort was immune dysfunction or allergies, with approximately 77% displaying some issues.
Among those with available data, 50% had abnormal T-cell populations. Meanwhile, 17% had some form of abnormalities of humoral immunity. Allergies were common in our cohort. Autoimmune disorders were also noted. Five individuals were diagnosed with idiopathic thrombocytopenic purpura, four with juvenile rheumatoid arthritis, four with Hashimoto's thyroiditis, two with Grave's disease, and one with vitiligo.
| Cardiac
Some form of congenital heart disease was present in 64% of patients, 42% of whom have complex or moderate defects (Billett et al., 2008) . Table 5 describes the common types of heart defects seen in our cohort. Ventricular septal defects were the most common abnormality identified on echocardiography. Tetralogy of Fallot was seen in 18%
of our cohort with a cardiac anomaly. Interestingly, patients with LCR22A-LCR22D deletions have a higher incidence of cardiac anomalies compared with patients with other nested LCR-mediated deletions (Supporting Information Figure S2 , p = 0.041, Pearson chisquared test).
| Craniofacial
Palatal anomalies were present in 67% of the patients studied. The vast majority of abnormalities were not overt clefts but rather submucous cleft palate (21%) or velopharyngeal dysfunction (VPD) (52%).
VPD can result from structural issues such as velopharyngeal disproportion, functional issues such as hypotonia of the velopharyngeal 
| Gastrointestinal
Gastrointestinal disease was noted in 65% of patients. Previous studies on our cohort revealed that dysphagia may be suggested by polyhydramnios prenatally and is overall seen in 30% of individuals.
Dysphagia often leads to supplemental enteral feeding strategies such as temporary nasogastric tube feeding (5%) or subsequent gastrostomy tube placement (16%). If individuals are able to transition to oral only feeding regimens, 95% do so by 4.5 years of age. Previous specialty studies suggest that dysmotility in the pharyngoesophageal area appears to be the major underlying feeding issue in most children (Eicher et al., 2000) . Thus, we suggest that when a patient presents in respiratory distress or is noted to have recurrent pulmonary infections or reactive airway disease, aspiration should be considered as a potential etiology.
Chronic constipation is also a common feature, with 35%
affected. Structural bowel anomalies such as intestinal malrotation, intestinal nonrotation, and feeding difficulties secondary to a vascular ring have also been identified. Hirschsprung disease, imperforate anus, and congenital diaphragmatic hernia are other visceral anomalies that occur more commonly among individuals with 22qDS compared to the general population.
| Endocrine
Over half of the patients in our cohort had an endocrinopathy, such as hypocalcemia, thyroid disease, and/or growth hormone deficiency.
Hypocalcemia was seen in 55% of patients at some point in their life regardless of perioperative period. There was a strong correlation with the severity of cardiac disease and the presence of hypocalcemia (p < 0.00001, τ = 0.31, Kendall's tau correlation). This suggests that hypocalcemia observed among individuals with 22q11.2DS may be partially related to critical illness in the setting of heart disease.
Nonetheless, 38% of individuals without heart disease also exhibited Other LCR-mediated deletion
Non-LCR-mediated deletion 2 hypocalcemia sometime during life. A separate study showed 80% of adults with 22q11.2DS experienced hypocalcemia during their lifetime, and that hypoparathyroidism, hypothyroidism, and hypomagnesaemia may contribute to hypocalcemia (Cheung et al., 2014) .
| Musculoskeletal
Data about musculoskeletal abnormalities were relatively poorly available in our cohort, but among those with available data, anomalies were common. Scoliosis was noted in 50% of the cohort. A cervical spine anomaly was noted in 46% of individuals, which is substantially lower than previous estimates, suggesting ascertainment bias due to a smaller number of patients being evaluated by Orthopedics (Homans et al., 2017) . Additional skeletal abnormalities included vertebral anomalies, talipes equinovarus, polydactyly, camptodactyly, patellar dislocation, and hammer toe (Homans et al., 2017; Ming et al., 1997) .
These findings underscore the importance of evaluation by an orthopedic surgeon. Diagnosis may result in activity changes such as avoiding contact sports as well as timely initiation of treatment.
| Genitourinary
Renal anomalies, mostly single hydronephrosis, renal agenesis, and multicystic dysplastic kidney, were seen in 16% our cohort. A recent study identified several genes that appear to be critical to the renal and urinary tract anomalies seen in patients with 22q11.2DS, with haploinsufficiency of CRKL appearing to be a primary genetic driver behind the phenotype (Lopez-Rivera et al., 2017). However, there was no significant difference in the number of renal abnormalities, including renal agenesis, between individuals with deletions involving the CRKL gene and those without (p = 1, Fisher exact test).
A separate genitourinary analysis on a subset of our cohort found that although hydronephrosis was the most common upper tract finding, the majority (63%) had isolated upper tract dilation without any additional diagnoses (Van Batavia et al. to be cited in special issue).
In terms of genital anomalies, boys were significantly more likely to be diagnosed with an abnormality than girls (8% vs. 0.5%, p < 0.001, Fisher exact test). Among males, 4% had cryptorchidism and 4% had hypospadias, which was noted to be mild (megameatus or glanular) in all except one boy. The only female genital anomalies noted were vaginal agenesis in two patients and uterine agenesis in one patient. Findings of hydronephrosis, unilateral renal agenesis, and multicystic dysplastic kidney occur at higher rates than expected in the general population; although in the majority of cases, no surgical intervention was necessary. Despite the higher than expected rate of hypospadias, most are mild distal hypospadias. The renal and genitourinary anomalies seen in this population emphasize the importance of a screening renal bladder ultrasound performed at the time of diagnosis of 22q11.2DS.
| Neurologic/psychiatric comorbidities
Neurologic and psychiatric comorbidities were common in our cohort.
Based on parental review of systems, 52% carried a diagnosis of attention deficit hyperactivity disorder (ADHD). This is slightly higher than other reports in the literature estimating 30-40% (Antshel et al., 2007; Green et al., 2009; Vorstman, et al., 2015) , but in contrast to the 12-13% estimated from other reports including a subset of our cohort (Hopkins et al., 2018 expect that the true number may be in between these estimates.
Autism spectrum disorder was seen in 19% of patients. Anxiety, behavior disorders, and psychotic disorders were also seen frequently.
CNS abnormalities included idiopathic seizures (15%), neural tube defects, polymicrogyria, microcephaly, hypotonia, and dystonia.
3.16 | Ear, nose, and throat, and respiratory
Chronic otitis media and chronic sinusitis are commonly reported in our cohort. These risks appear to be secondary to underlying immune deficiencies and palatal differences in patients with 22q11.2DS. Previous studies showed that these issues may result in conductive hearing loss, although sensorineural hearing loss and mixed hearing loss were also seen. A previous study of 104 individuals in our cohort, ranging from 5 months to 37 years, who underwent an otolaryngology procedure (microlaryngoscopy or bronchoscopy) demonstrated that 71% had airway abnormalities. Airway abnormalities included tracheomalacia (36%), subglottic stenosis (28%), laryngomalacia (26%), glottic web (21%), and bronchomalacia (16%). Additional issues observed in our cohort include vocal cord paralysis, choanal atresia, tracheoesophageal fistula, tracheal atresia, and microtia. Tracheostomy was required in 30% of patients undergoing otolaryngology proceedures (Sacca et al., 2017) . The high proportion of airway abnormalities in those undergoing airway evaluation shows the importance of prompt referral to otolaryngology when issues are suspected.
| Ophthalmology
Patients exhibited a number of ocular issues, including sclerocornea, posterior embryotoxon, tortuous retinal vessels, strabismus, ptosis, amblyopia, tilted optic nerves, cataracts, and/or colobomas (Binenbaum et al., 2008; Forbes et al., 2007) . The number of patients with astigmatism, myopia, and hyperopia is comparable to the number of people affected by those conditions in the general population. The high proportion of abnormalities identified shows the importance of an initial ophthalmology examination, with follow-up as dictated by the initial visit.
| Hematology and oncology
Patients with 22q11.2DS may have macrothrombocytopenia (baseline thrombocytopenia with increased MPV) as well as an increased risk of autoimmune cytopenias, which tend to be recurrent. Management recommendations are the same as for patients without 22q11.2DS (Lambert et al., 2017) .
Although rare, 6% of patients had malignancies including hepatoblastoma, Wilms tumor, renal cell carcinoma, thyroid carcinoma, melanoma, and leukemia. Previous studies have suggested that the overall malignancy rate is higher among our cohort than age-adjusted population estimates (Lambert et al., 2017) ; however, larger studies will be required to definitively identify specific tumors that are more common among individuals with 22q11.2 deletions.
| Transition to adult care
As is evident by the aging population, there is a large need for transitional care. We have created a transitional care program with the Division of Translational Medicine and Human Genetics at the University of Pennsylvania and have evaluated 13 patients. These patients were evaluated by a single medical geneticist (S.K.). Patients were frequently diagnosed in pregnancy because of an affected fetus (five patients). Medical issues were similar to our pediatric cohort. Neuropsychiatric issues were also prevalent; five patients had anxiety, four had ADHD, and one had psychosis. About half (six patients) are living independently with their own partners/children, whereas the remaining seven patients reside within their childhood home. Of these 13 adults, eight graduated from high school, one graduated from college, two are enrolled in college courses. Six of the 13 are employed. We believe this program will be important for the continued management as well as evaluation of the natural history of our cohort.
| Dual diagnoses
There were also a number of patients in our cohort with another significant syndrome/condition, in addition to the 22q11.2 deletion.
These include severe combined immunodeficiency, Marfan syndrome, two patients with CHARGE (OMIM #214800, because of CHD7 pathogenic variants), cystic fibrosis (OMIM #21970), Ehlers-Danlos syndrome (OMIM #130000), Trisomy 8 mosaicism, and several with an additional potentially pathogenic copy number variation. Six patients also had autosomal recessive conditions unmasked by a 22q11.2 deletion, Bernard-Soulier syndrome (OMIM #231200, GP1BB pathogenic variant), and CEDNIK syndrome (OMIM #609528, SNAP29 pathogenic variant) (Cohen et al., 2018) .
| Mortality
We observed a 4% mortality rate overall. Most of these deaths were related to complex congenital heart disease. The median age at death was 5 months. This is in contrast to the median age at death of 41.5 years from a prior study of adults with 22q11.2DS and is likely because of the age of our cohort (Bassett et al., 2009 ).
| DISCUSSION
To our knowledge, this is the largest longitudinal study of 22q11.2DS.
The size of our patient population allowed us to more accurately characterize the demographics, dysmorphology, molecular etiologies, common medical issues, and neurodevelopmental outcomes of this disease. Notably, 74% of our cohort described themselves as Caucasian, with only 9% being of African descent, differing demographically from our general hospital population of approximately 35% African
American. Analysis of physical examination findings by race suggests that some common facial features are either less common or more difficult to identify clinically in non-Caucasian patients, potentially hindering diagnosis. Alternative explanations include differences in access to our referral center or possibly population variations in a heritable predisposition to development of 22q11.2 deletions (Demaerel et al., 2017) .
Our findings confirm that the range of behavioral and developmental phenotypes that can be seen in patients with the 22q11.2 deletion is considerable McDonald-McGinn et al., 2001; Kruszka et al.,2017) . Previous studies revealed that delays in reaching motor milestones and emergence of language are common in children with 22q11.2DS Solot et al., 2001) . Our findings suggest that motor delays are somewhat less severe and may be associated with congenital heart disease. Meanwhile, language delays are more prominent and do not correlate with major medical issues. We find that measured FSIQ is significantly below normal, although there is likely ascertainment bias in that individuals with apparently low IQ are more likely to have formal testing. We also found that neuropsychiatric disorders such as autism and ADHD are common in our cohort. The majority of the children in our cohort have an IEP. We suspect the remaining 7% merit an IEP but are either still too young or attend school in poor districts. Notably, not all patients necessarily had standardized formal diagnosis according to DSM-5 criteria, which is a potential weakness of our analysis.
Similar to previously published information Repetto et al., 2014; Ryan et al., 1997) , we find that congenital heart defects are extremely common in 22q11.2DS. We find that rare congenital heart abnormalities such as interrupted aortic arch and vascular rings are frequent among our patients. We find that palate abnormalities are also common, despite that reported incidence of palatal anomalies in the literature varies greatly, from 9% to 98% (Cohen, Chow, Weksberg, & Bassett, 1999; Driscoll et al., 1993; McDonald-McGinn et al., 1999) . These discrepancies are likely because of variations in authors' classification of palate abnormalities.
Overall, our analysis of this cohort provides an in-depth view of the phenotypic spectrum associated with the 22q11.2DS. We illustrate the importance of early diagnosis due to the medical complexity of these patients. Although not every individual received formalized testing in each area, our data estimate the prevalence of various features. As our cohort ages, we will further identify and classify medical comorbidities that develop during adulthood.
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